542.32 USD
-5.04 (-0.92%)
543 USD
+0.68 (+0.13%)
We assign a fundamental rating of 7 out of 10 to ISRG. ISRG was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ISRG is growing strongly while it is still valued neutral. This is a good combination! With these ratings, ISRG could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
ISRG had a positive operating cash flow in the past year.
Each year in the past 5 years ISRG has been profitable.
Each year in the past 5 years ISRG had a positive operating cash flow.
1.2 Ratios
ISRG has a better Return On Assets (14.19%) than 96.26% of its industry peers.
ISRG has a better Return On Equity (16.12%) than 91.44% of its industry peers.
ISRG's Return On Invested Capital of 14.96% is amongst the best of the industry. ISRG outperforms 95.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ISRG is above the industry average of 8.80%.
The 3 year average ROIC (12.20%) for ISRG is below the current ROIC(14.96%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 14.96% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
The Profit Margin of ISRG (28.58%) is better than 96.79% of its industry peers.
In the last couple of years the Profit Margin of ISRG has declined.
The Operating Margin of ISRG (29.44%) is better than 96.79% of its industry peers.
In the last couple of years the Operating Margin of ISRG has declined.
ISRG has a better Gross Margin (66.38%) than 70.05% of its industry peers.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ISRG is still creating some value.
The number of shares outstanding for ISRG has been increased compared to 1 year ago.
The number of shares outstanding for ISRG has been increased compared to 5 years ago.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.69
WACC8.83%
2.3 Liquidity
ISRG has a Current Ratio of 4.97. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.97, ISRG is doing good in the industry, outperforming 77.54% of the companies in the same industry.
A Quick Ratio of 4.20 indicates that ISRG has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.20, ISRG is in the better half of the industry, outperforming 77.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.12%, which is quite impressive.
The Earnings Per Share has been growing by 11.48% on average over the past years. This is quite good.
ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.18%.
ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.47% yearly.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.12% yearly.
EPS Next Y20.12%
EPS Next 2Y16.31%
EPS Next 3Y15.91%
EPS Next 5Y15.47%
Revenue Next Year21.33%
Revenue Next 2Y18.1%
Revenue Next 3Y16.47%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 62.99, the valuation of ISRG can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 67.91% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.54, ISRG is valued quite expensively.
Based on the Price/Forward Earnings ratio of 54.69, the valuation of ISRG can be described as expensive.
ISRG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 68.98% of the companies in the same industry.
ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.99 | ||
| Fwd PE | 54.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than the industry average as 66.31% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ISRG is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.64 | ||
| EV/EBITDA | 53.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ISRG's earnings are expected to grow with 15.91% in the coming years.
PEG (NY)3.13
PEG (5Y)5.49
EPS Next 2Y16.31%
EPS Next 3Y15.91%
5. Dividend
5.1 Amount
No dividends for ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
542.32
-5.04 (-0.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.16%
Inst Owner Change3.08%
Ins Owners0.45%
Ins Owner Change1.29%
Market Cap192.25B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78
Price Target613.44 (13.11%)
Short Float %2.12%
Short Ratio3.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)0.78%
PT rev (3m)2.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.25%
EPS NY rev (1m)0.16%
EPS NY rev (3m)5.77%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.99 | ||
| Fwd PE | 54.69 | ||
| P/S | 20 | ||
| P/FCF | 84.64 | ||
| P/OCF | 64.94 | ||
| P/B | 11.28 | ||
| P/tB | 11.52 | ||
| EV/EBITDA | 53.81 |
EPS(TTM)8.61
EY1.59%
EPS(NY)9.92
Fwd EY1.83%
FCF(TTM)6.41
FCFY1.18%
OCF(TTM)8.35
OCFY1.54%
SpS27.11
BVpS48.07
TBVpS47.09
PEG (NY)3.13
PEG (5Y)5.49
Graham Number96.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 14.96% | ||
| ROICexc | 29.62% | ||
| ROICexgc | 30.86% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.83%
ROIC/WACC1.69
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y20.12%
EPS Next 2Y16.31%
EPS Next 3Y15.91%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.33%
Revenue Next 2Y18.1%
Revenue Next 3Y16.47%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year45.62%
EBIT Next 3Y24.72%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 7 / 10.